ArticleGynecologic oncology reports2026

Pathological complete response following systemic therapy with carboplatin-paclitaxel plus pembrolizumab for initially unresectable mismatch repair-deficient advanced endometrial cancer: two case reports.

Nanami Uetake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.